HYPERPHOSPHATASAEMIA

HYPERPHOSPHATASAEMIA was reported 110 times

HYPERPHOSPHATASAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CCR5 Co-receptor Antagonist [EPC] 4 0.0017
1 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
2 Somatostatin Analog [EPC] 1 0.0001
3 Programmed Death Ligand-1 Blocker [EPC] 3 0.0001
4 Protease Inhibitor [EPC] 6 0.0001
5 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
6 Bile Acid [EPC] 3 0.0001
7 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1 0.0001
8 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
9 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
10 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
11 Cytochrome P450 3A Inhibitor [EPC] 6 0.0001
12 Vitamin D3 Analog [EPC] 2 0.0001
13 Bile Acid Sequestrant [EPC] 1 0.0001
14 Lipid-based Polyene Antifungal [EPC] 1 0.0001
15 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
16 Parenteral Iron Replacement [EPC] 1 0.0001
17 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
18 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7 0.0001
20 Calcineurin Inhibitor Immunosuppressant [EPC] 8 0.0001
21 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
22 Antimetabolite Immunosuppressant [EPC] 1 0.0000
23 Recombinant Human Growth Hormone [EPC] 1 0.0000
24 Cardiac Glycoside [EPC] 3 0.0000
25 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
26 Typical Antipsychotic [EPC] 1 0.0000
27 Macrolide Antimicrobial [EPC] 2 0.0000
28 Complement Inhibitor [EPC] 2 0.0000
29 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
30 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 10 0.0000
32 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
33 Azole Antifungal [EPC] 4 0.0000
34 Polyene Antifungal [EPC] 1 0.0000
35 Nucleoside Analog Antiviral [EPC] 2 0.0000
36 Mood Stabilizer [EPC] 5 0.0000
37 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
38 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
39 Proteasome Inhibitor [EPC] 2 0.0000
40 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
41 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
42 Sulfonylurea [EPC] 2 0.0000
43 BCL-2 Inhibitor [EPC] 1 0.0000
44 Loop Diuretic [EPC] 6 0.0000
45 Aldosterone Antagonist [EPC] 2 0.0000
46 Proton Pump Inhibitor [EPC] 7 0.0000
47 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
48 Platinum-based Drug [EPC] 3 0.0000
49 Purine Antimetabolite [EPC] 1 0.0000
50 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
51 Anti-epileptic Agent [EPC] 2 0.0000
52 Parathyroid Hormone Analog [EPC] 1 0.0000
53 Aromatase Inhibitor [EPC] 1 0.0000
54 Fluoroquinolone Antibacterial [EPC] 1 0.0000
55 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
56 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
57 Kinase Inhibitor [EPC] 4 0.0000
58 Leukocyte Growth Factor [EPC] 1 0.0000
59 Osmotic Laxative [EPC] 2 0.0000
60 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
61 Corticosteroid [EPC] 8 0.0000
62 Platelet Aggregation Inhibitor [EPC] 3 0.0000
63 RANK Ligand Inhibitor [EPC] 1 0.0000
64 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
65 Alkylating Drug [EPC] 1 0.0000
66 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
67 Opioid Agonist [EPC] 1 0.0000
68 Vitamin D [EPC] 1 0.0000
69 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
70 Vitamin B12 [EPC] 1 0.0000
71 Vitamin C [EPC] 1 0.0000
72 Insulin Analog [EPC] 1 0.0000
73 Atypical Antipsychotic [EPC] 1 0.0000
74 Benzodiazepine [EPC] 1 0.0000
75 Tumor Necrosis Factor Blocker [EPC] 1 0.0000